Pfm Health Sciences, LP Laboratory Corp Of America Holdings Transaction History

Pfm Health Sciences, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$203.72 - $248.97 $2.76 Million - $3.38 Million	13,561 New	13,561 $3.19 Million
Q3 2021 Nov 15, 2021	SELL	$274.82 - $308.34 $17.5 Million - $19.6 Million	-63,640 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$251.87 - $278.14 $16 Million - $17.7 Million	63,640 New	63,640 $17.6 Million
Q1 2021 May 17, 2021	SELL	$204.88 - $255.03 $26.2 Million - $32.7 Million	-128,100 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$186.91 - $214.42 $2.85 Million - $3.26 Million	-15,223 Reduced 10.62%	128,100 $26.1 Million
Q3 2020 Nov 16, 2020	SELL	$167.03 - $201.3 $27.9 Million - $33.6 Million	-167,007 Reduced 53.82%	143,323 $27 Million
Q2 2020 Aug 14, 2020	BUY	$113.31 - $182.44 $35.2 Million - $56.6 Million	310,330 New	310,330 $51.5 Million

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.6B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Pfm Health Sciences, LP, based on Form 13F filings with the SEC.

Stay updated on Pfm Health Sciences, LP with notifications on news.